| Bioactivity | Etidocaine (hydrochloride) is a long aminoamide local anesthetic[1]. | ||||||||||||
| Invitro | IGL-EDC formulations can induce a significant increase in human fibroblasts survival[1]. Cell Viability Assay Cell Line: | ||||||||||||
| In Vivo | Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit[2]. Animal Model: | ||||||||||||
| Name | Etidocaine hydrochloride | ||||||||||||
| CAS | 36637-19-1 | ||||||||||||
| Formula | C17H29ClN2O | ||||||||||||
| Molar Mass | 312.88 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Oliveira, et al. Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity. Pharmaceutical research vol. 35, 12 229. 10 Oct. 2018. [2]. Langerman, L, et al. The partition coefficient as a predictor of local anesthetic potency for spinal anesthesia: evaluation of five local anesthetics in a mouse model. Anesthesia and analgesia vol. 79,3 (1994): 490-4. |